Literature DB >> 1486101

Are CSF or serum ganglioside antibodies related to peripheral nerve demyelination in neuroborreliosis, Guillain-Barré syndrome, or chronic inflammatory demyelinating polyradiculoneuropathy?

M Weller1, A Stevens, N Sommer, H Wiethölter.   

Abstract

Cerebrospinal fluid (CSF) and serum IgG and IgM antibodies to seven gangliosides were determined in patients with neuroborreliosis (NB) (n = 20), Guillain-Barré syndrome (GBS) (n = 13), and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) (n = 10). The incidence of elevated antibodies was highest in NB and lowest in CIDP. Correlation between CSF and serum antibodies was only observed for IgG antibodies to GM1, GD1b and GT1b in GBS. The strong IgM antibody reactivity to gangliosides in the CSF of NB patients may be involved in the variety of neurological disorders attributed to Borrelia burgdorferi infection. Since one CIDP and three GBS patients had serologic evidence of prior or concurrent borrelia infection, this infection may belong to the infections that can trigger GBS or CIDP. The lack of specific ganglioside antibody patterns in these four patients suggests that ganglioside antibodies are not the link between Borrelia burgdorferi infection and the demyelination of peripheral nerves in GBS and CIDP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1486101     DOI: 10.1007/bf02191559

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Predictive value of anti-GM1 ganglioside antibodies in neuromuscular diseases: a study of 180 sera.

Authors:  D Adams; T Kuntzer; D Burger; M Chofflon; M R Magistris; F Regli; A J Steck
Journal:  J Neuroimmunol       Date:  1991-06       Impact factor: 3.478

2.  Glutaraldehyde-enhanced immunofixation: a sensitive new method for detecting oligoclonal immunoglobulin M.

Authors:  M K Sharief; G Keir; E J Thompson
Journal:  J Neuroimmunol       Date:  1989-07       Impact factor: 3.478

3.  A prospective study of acute idiopathic neuropathy II antecedent events.

Authors:  G L Mancardi; M Del Sette; A Primavera; M Farinelli; D Fumarola
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-03       Impact factor: 10.154

4.  [Cerebrospinal fluid changes in Garin-Bujadoux-Bannwarth meningoradiculitis].

Authors:  E Maida; W Kristoferitsch; G Spiel
Journal:  Nervenarzt       Date:  1986-03       Impact factor: 1.214

5.  Criteria for diagnosis of Guillain-Barré syndrome.

Authors: 
Journal:  Ann Neurol       Date:  1978-06       Impact factor: 10.422

6.  Measurement and significance of antibodies against GM1 ganglioside. Report of a workshop, 18 April 1989, Chicago, IL, U.S.A.

Authors:  D M Marcus; N Latov; B P Hsi; B K Gillard
Journal:  J Neuroimmunol       Date:  1989-12       Impact factor: 3.478

7.  Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease.

Authors:  J J Halperin; G P Kaplan; S Brazinsky; T F Tsai; T Cheng; A Ironside; P Wu; J Delfiner; M Golightly; R H Brown
Journal:  Arch Neurol       Date:  1990-05

8.  Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.

Authors:  C L Koski; R Humphrey; M L Shin
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

9.  Central nervous system manifestations of Lyme disease.

Authors:  A R Pachner; P Duray; A C Steere
Journal:  Arch Neurol       Date:  1989-07

10.  The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis.

Authors:  A R Pachner; A C Steere
Journal:  Neurology       Date:  1985-01       Impact factor: 9.910

View more
  3 in total

1.  Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides.

Authors:  J C Garcia-Monco; R J Seidman; J L Benach
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

2.  Phospholipidomic Analysis Reveals Changes in Sphingomyelin and Lysophosphatidylcholine Profiles in Plasma from Patients with Neuroborreliosis.

Authors:  W Łuczaj; P Domingues; M R Domingues; S Pancewicz; E Skrzydlewska
Journal:  Lipids       Date:  2016-11-10       Impact factor: 1.880

3.  Myelin- and microbe-specific antibodies in Guillain-Barré syndrome.

Authors:  J Terryberry; M Sutjita; Y Shoenfeld; B Gilburd; D Tanne; M Lorber; I Alosachie; N Barka; H C Lin; P Youinou
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.